[HTML][HTML] Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review
V Di Lauro, G Barchiesi, F Martorana, G Zucchini… - ESMO open, 2022 - Elsevier
Background Evaluation of health-related quality of life (HR-QoL) among cancer patients has
gained an increasing importance and is now a key determinant of anticancer treatments' …
gained an increasing importance and is now a key determinant of anticancer treatments' …
Managing a Long and Winding Road: Estrogen Receptor–Positive Breast Cancer
M Gnant, NC Turner, C Hernando - American Society of Clinical …, 2023 - ascopubs.org
We review key topics in the management of estrogen receptor (ER)–positive human
epidermal growth factor receptor 2–negative breast cancer. The single biggest challenge in …
epidermal growth factor receptor 2–negative breast cancer. The single biggest challenge in …
乳腺癌CDK4/6 抑制剂相关性不良反应管理共识.
葛睿， 王碧芸， 江泽飞 - Chinese Journal of Oncology, 2022 - search.ebscohost.com
细胞周期蛋白依赖性激酶4/6 (CDK4/6) 抑制剂是治疗激素受体阳性乳腺癌的抗肿瘤药物, 其中,
哌柏西利, 阿贝西利和达尔西利已在中国获得批准用于乳腺癌的治疗. CDK4/6 …
哌柏西利, 阿贝西利和达尔西利已在中国获得批准用于乳腺癌的治疗. CDK4/6 …
Anti-hormonal therapy in breast cancer and its effect on the blood-brain barrier
Simple Summary Anti-hormonal therapie regimes are well established in oncological
treatments in breast cancer. In contrast there is limited knowledge of their effects on …
treatments in breast cancer. In contrast there is limited knowledge of their effects on …
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2− Advanced Breast Cancer: Results from the Italian Subpopulation of Phase …
M De Laurentiis, R Caputo, M Mazza, M Mansutti… - Targeted Oncology, 2022 - Springer
Background Ribociclib plus letrozole demonstrated manageable safety and efficacy profiles
in hormone receptor–positive (HR+), human epidermal growth factor receptor-2–negative …
in hormone receptor–positive (HR+), human epidermal growth factor receptor-2–negative …
Updated review article: cyclin-dependent kinase 4/6 inhibitor impact, FDA approval, and resistance pathways
RJ Hunter, J Park, KJ Asprer… - Journal of Pharmacy …, 2023 - journals.sagepub.com
Objective: To describe the mechanism of cyclin-dependent kinase (CDK) 4/6 inhibitors,
mechanisms of resistance, and summarize various clinical trials used to determine the …
mechanisms of resistance, and summarize various clinical trials used to determine the …
[HTML][HTML] Therapy algorithms for the diagnosis and treatment of patients with early and advanced breast cancer
A Schneeweiss, I Bauerfeind, T Fehm, W Janni… - Breast Care, 2020 - karger.com
Background: In order to offer optimal treatment approaches based on available evidence,
the Commission Breast of the Working Group Gynecologic Oncology (AGO) of the German …
the Commission Breast of the Working Group Gynecologic Oncology (AGO) of the German …
乳腺癌内分泌治疗药物药学服务指南(2023 版).
李国辉， 马飞 - Chinese Journal of Oncology, 2023 - search.ebscohost.com
内分泌治疗是激素受体阳性(HR+) 乳腺癌患者的主要治疗方法之一. 截至2023 年6 月1 日,
国家药品监督管理局已批准56 个用于HR+/人表皮生长因子受体2 阴性(HER⁃ 2-) …
国家药品监督管理局已批准56 个用于HR+/人表皮生长因子受体2 阴性(HER⁃ 2-) …
A eficácia dos novos tratamentos de hormonioterapia na sobrevida livre de progressão de pacientes com câncer de mama metastático RH+/HER2-: uma revisão …
LR da Silva, N de Lima Queiroz… - Research, Society and …, 2021 - rsdjournal.org
Objective: Breast cancer is the most prevalent cancer that affects women, second only to non-
melanoma skin cancers. Cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitors are the latest …
melanoma skin cancers. Cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitors are the latest …
Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review
S Chen, Y Ren, H Dai, Y Li, B Lan… - Expert Review of …, 2021 - Taylor & Francis
Introduction Drug-induced pulmonary toxicity (DIPT) associated with breast cancer (BC)
therapy has been a major concern in recent times. DIPT may not be attributed to a single …
therapy has been a major concern in recent times. DIPT may not be attributed to a single …